IRCT20221002056071N1招募中3 期
Evaluation of the effect of royal jelly consumption on inflammatory mediators including interleukin-1-beta, interleukin-6, interferon-gamma and tumor necrosis factor in patients with multiple sclerosis
Dezfoul University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 45 years（—）
- 性别
- All
入选标准
- •Inclusion criteria of participants:: Patients' subtype of M.S should be the relapsing-remitting MS (RRMS). The patient's age should be 20- 45 years old and all of them treated with interferon for at least 6 months.
排除标准
- •Patients with anemia, chronic heart disease, lung disease, diabetic Mellitus, autoimmune diseases such as rheumatoid arthritis, SLE, liver diseases, and a history of asthma and allergies. Patients are treated with corticosteroids or ACTH drugs, or consumption of supplements.
研究者
相似试验
已完成
2 期
The effects of enteral Royal jelly supplementation in critically ill patientsSupportive care critically ill patient stay in intentensive care unit.Symptoms and signs involving the digestive system and abdomenIRCT2016073029127N1Vice chancellor for research, Tehran University of Medical Sciences30
已完成
不适用
The effects of royal jelly for the adverse events of molecular target therapy for renal cancer patients.Renal cell carcinomaJPRN-UMIN000020152Department of Urology and Renal transplantation, Nagasaki University Hospital60
招募中
3 期
Investigation on the influence of royal jelly oral intake for endothelial cell function in patients with hemodialysisHemodialysisJPRN-jRCTs071200031Ohba Kojiro270
招募中
2 期
Investigating the effect of royal jelly supplement in non-alcoholic fatty liver diseaseon-alcoholic fatty liver.Fatty (change of) liver, not elsewhere classifiedK76.0IRCT20110510006431N7Shahid Beheshti University of Medical Sciences46
已完成
3 期
Effect of royal jelly in treatment of strokeIRCT20180818040827N4Esfahan University of Medical Sciences64